Literature DB >> 22988594

hERG K(+) channels: structure, function, and clinical significance.

Jamie I Vandenberg1, Matthew D Perry, Mark J Perrin, Stefan A Mann, Ying Ke, Adam P Hill.   

Abstract

The human ether-a-go-go related gene (hERG) encodes the pore-forming subunit of the rapid component of the delayed rectifier K(+) channel, Kv11.1, which are expressed in the heart, various brain regions, smooth muscle cells, endocrine cells, and a wide range of tumor cell lines. However, it is the role that Kv11.1 channels play in the heart that has been best characterized, for two main reasons. First, it is the gene product involved in chromosome 7-associated long QT syndrome (LQTS), an inherited disorder associated with a markedly increased risk of ventricular arrhythmias and sudden cardiac death. Second, blockade of Kv11.1, by a wide range of prescription medications, causes drug-induced QT prolongation with an increase in risk of sudden cardiac arrest. In the first part of this review, the properties of Kv11.1 channels, including biogenesis, trafficking, gating, and pharmacology are discussed, while the second part focuses on the pathophysiology of Kv11.1 channels.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22988594     DOI: 10.1152/physrev.00036.2011

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  234 in total

Review 1.  hERG quality control and the long QT syndrome.

Authors:  Brian Foo; Brittany Williamson; Jason C Young; Gergely Lukacs; Alvin Shrier
Journal:  J Physiol       Date:  2016-02-09       Impact factor: 5.182

2.  Gasping for answers. Focus on "Calpain activation by ROS mediates human ether-a-go-go-related gene protein degradation by intermittent hypoxia".

Authors:  Ramon J Ayon; Haiyang Tang; Jason X-J Yuan
Journal:  Am J Physiol Cell Physiol       Date:  2016-02-03       Impact factor: 4.249

Review 3.  Comprehensive review of cardiovascular toxicity of drugs and related agents.

Authors:  Přemysl Mladěnka; Lenka Applová; Jiří Patočka; Vera Marisa Costa; Fernando Remiao; Jana Pourová; Aleš Mladěnka; Jana Karlíčková; Luděk Jahodář; Marie Vopršalová; Kurt J Varner; Martin Štěrba
Journal:  Med Res Rev       Date:  2018-01-05       Impact factor: 12.944

Review 4.  Towards a Structural View of Drug Binding to hERG K+ Channels.

Authors:  Jamie I Vandenberg; Eduardo Perozo; Toby W Allen
Journal:  Trends Pharmacol Sci       Date:  2017-07-12       Impact factor: 14.819

5.  Calpain activation by ROS mediates human ether-a-go-go-related gene protein degradation by intermittent hypoxia.

Authors:  N Wang; H S Kang; G Ahmmed; S A Khan; V V Makarenko; N R Prabhakar; J Nanduri
Journal:  Am J Physiol Cell Physiol       Date:  2015-12-09       Impact factor: 4.249

Review 6.  Predicting drug metabolism: experiment and/or computation?

Authors:  Johannes Kirchmair; Andreas H Göller; Dieter Lang; Jens Kunze; Bernard Testa; Ian D Wilson; Robert C Glen; Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2015-04-24       Impact factor: 84.694

7.  Tuning HERG out: antitarget QSAR models for drug development.

Authors:  Rodolpho C Braga; Vinicius M Alves; Meryck F B Silva; Eugene Muratov; Denis Fourches; Alexander Tropsha; Carolina H Andrade
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

8.  Escitalopram block of hERG potassium channels.

Authors:  Yun Ju Chae; Ji Hyun Jeon; Hong Joon Lee; In-Beom Kim; Jin-Sung Choi; Ki-Wug Sung; Sang June Hahn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-09-18       Impact factor: 3.000

9.  Cryo-EM Structure of the Open Human Ether-à-go-go-Related K+ Channel hERG.

Authors:  Weiwei Wang; Roderick MacKinnon
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

10.  Rescue of protein expression defects may not be enough to abolish the pro-arrhythmic phenotype of long QT type 2 mutations.

Authors:  Matthew D Perry; Chai Ann Ng; Kevin Phan; Erikka David; Kieran Steer; Mark J Hunter; Stefan A Mann; Mohammad Imtiaz; Adam P Hill; Ying Ke; Jamie I Vandenberg
Journal:  J Physiol       Date:  2016-05-27       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.